Imatinib: As Adjuvant Therapy for Gastrointestinal Stromal Tumor†: Profile Report

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.3, 2011-06, pp. : 191-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

KIT and BRAF Mutational Status in a Patient with a Synchronous Lentigo Maligna Melanoma and a Gastrointestinal Stromal Tumor

By Matin Rubeta N.

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 64-65

Adis International

Access to resources Recommend Favorite

Rituximab as First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma†: Profile Report

By Croxtall Jamie D.

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 329-331

Adis International

Access to resources Recommend Favorite

Sclerosing stromal tumor of the ovary: ultrasound elastography and MRI findings on preoperative diagnosis

By Onur Mehmet

Journal of Medical Ultrasonics, Vol. 38, Iss. 4, 2011-10 ,pp. : 217-220

Springer Publishing Company

Access to resources Recommend Favorite

Ecallantide in Acute Hereditary Angioedema†: Profile Report

By Garnock-Jones Karly P.

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 51-52

Adis International

Access to resources Recommend Favorite